Welcome to UCB's media room

Our media relations team aims to serve the media with timely, valuable and reliable information. This section offers resources for journalists, editors and other media professionals.

66th American Epilepsy Society Annual Meeting

News Alerts

First name: *

Last name: *

Email address: *

Contact Us

For general media related enquiries contact:
+32 (0)25599274 or email us.

Latest News

Acquisition of own shares in the framework of employees’ long-term incentive plans

02-Feb-2012

UCB and Astellas announce agreement to jointly develop and commercialize Cimzia® (certolizumab pegol) in Japan

01-Feb-2012

Transparency Notification of Wellington management Company LLP

27-Jan-2012

Acquisition of own shares in the framework of employees’ long-term incentive plans

26-Jan-2012

UCB announces FDA approval for Keppra® in infants and children from one month of age with partial onset seizures

25-Jan-2012

BioPilot Plant

UCB started construction of its biotechnology pilot plant in Braine-l'Alleud, Belgium.
The main goal of the biotechnological pilot plant's laboratories will be to speed up availability of biotechnological drugs for serious illnesses, concentrating on pilot projects and delivering product for clinical trial activities.